Sevrina Tekle
About Sevrina Tekle
Sevrina Tekle is an Undergraduate Research Assistant at Vanderbilt University, focusing on cancer immunotherapy research involving core/shell particles.
Current Position at Vanderbilt University
Sevrina Tekle is currently employed at Vanderbilt University as an Undergraduate Research Assistant. In this role, she focuses on the design, fabrication, and characterization of core/shell particles intended for sustained release of cancer immunotherapies. Her research involves using electrospray techniques to prepare PLGA/protein particles, which are then assessed for physiochemical properties and protein release rates. Additionally, she performs in vitro assessments within mammalian cell cultures.
Previous Experience at Vanderbilt Institute of Nanoscale Science and Engineering (VINSE)
Sevrina Tekle has previous experience working at the Vanderbilt Institute of Nanoscale Science and Engineering (VINSE) as a Technical Crew member. She held this position from 2019 to 2020 for a duration of one year in Nashville, Tennessee. During her tenure, she gained hands-on experience and technical skills that contributed to her foundational knowledge in nanoscale science and engineering.
Educational Background
Sevrina Tekle attended Vanderbilt University, where she pursued a Bachelor of Science in Engineering Science from 2018 to 2022. At Vanderbilt, she developed a strong foundation in various scientific and engineering principles, which has greatly contributed to her current research endeavors. Prior to attending university, she completed her high school education at Meadowcreek High School, earning her High School Diploma from 2014 to 2018.
Research Focus and Techniques
Sevrina Tekle's research is concentrated on the preparation and characterization of core/shell particles for cancer immunotherapy. She employs electrospray techniques to develop PLGA/protein particles, which are integral to her studies. Her research includes characterizing these particles for their physiochemical properties and protein release rates. In addition to her technical work, Sevrina also conducts in vitro assessments using mammalian cell cultures to evaluate the efficacy and potential applications of her findings.